Increased prevalence of GSTM1 null genotype in patients with myelodysplastic syndrome: A case-control study

Acta Haematologica

Volumn 104, Issue 4, 2000, Pages 169-173

  Tsabouri, S E ^a   Georgiou, I ^a   Alamanos, I ^a   Bourantas, K L ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b Department of Internal Medicine Hematology ^*  (Greece)

Author keywords

Glutathione S transferase; GSTM1; GSTT1; Myelodysplastic syndromes

Indexed keywords

GLUTATHIONE TRANSFERASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CYTOPENIA; DISEASE PREDISPOSITION; DNA DETERMINATION; FEMALE; GENOTYPE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LYMPHOCYTE CULTURE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

AGE FACTORS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; GENE DELETION; GENOTYPE; GLUTATHIONE TRANSFERASE; MATCHED-PAIR ANALYSIS; MYELODYSPLASTIC SYNDROMES; ODDS RATIO; PREVALENCE; SEX FACTORS; SMOKING;

EID: 0034465064     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046510     Document Type: Article

References (29)

1. Myelodysplastic syndromes (preleukemia)
2. Clonal analysis of myelodysplastic syndromes: Evidence of multipotent stem cell origin
3. Classification and morphologic features of the myelodysplastic syndromes
4. The French-American-British (FAB) Co-operative Group: Proposals for the classification of the myelodysplastic syndromes
5. Dysmyelopoietic syndromes. A search for prognostic factors in 193 patients
6. Myelodysplastic syndromes. A system with prognostic significance
7. The myelodysplastic syndromes: Current approaches to therapy
8. Leukemias and myelodysplastic syndromes secondary to drug, radiation and environmental exposure
9. Malignancies due to occupational exposure to benzene
10. Protective role of glutathione transferases in mutagenesis and carcinogenesis
11. 1) gene defect
12. 1) gene defect in myelodysplasia and acute myeloid leukemia
13. Glutathione S-transferase gene deletion in myelodysplasia
14. Gene deletion of glutathione S-transferase theta: Correlation with induced genetic damage and potential role in endogenous mutagenesis
15. 1) that increases susceptibility to bladder cancer
16. Simple estimation of population attributable risk from case-control studies
17. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes
18. Is environmental carcinogenesis modulated by host polymorphism
19. Glutathione transferase structure and catalytic activity
20. Genetic heterogeneity of the human glutathione transferases: A complex of gene families
21. Nomenclature for human glutathione transferases
22. Biochemical genetics of glutathione S-transferases in man
23. Gene deletion and partial deficiency of the glutathione transferases (ligandin) system in man
24. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion
25. Glutathione S-transferase M)1(and T)1 polymorphisms: Susceptibility to colon cancer and age of onset
26. 1 genetic polymorphism and susceptibility to bladder, breast and colon cancer
27. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta
28. Increased risk of lung cancer in Japanese smokers with class mu glutathione S-transferase gene deficiency
29. Use of isolated inbred human populations for identification of disease genes